For months, the most important acquisition seat at the Defense Health Agency carried an "Acting" label. The Component Acquisition Executive, the person with final say over every medical-systems and health IT buy at the component level, was a placeholder while the April reorg sorted itself out.

That changed. The seat is confirmed. Not acting, confirmed.

I am not putting the name in this email, because a name drop is not the point. What matters for your pipeline is this: the person holding final acquisition decision authority at DHA is no longer provisional. That changes who signs, who you invest a relationship in, and how much weight to give a "we are still standing up" answer when DHA hands you one.

I updated the DHA org chart with the confirmed CAE, the background that actually tells you something, and where this seat sits against the three-PAE consolidation running into the July 19 Full Operating Capability date. The full org chart is part of MMT Premium.

See the confirmed CAE on the DHA org chart

Go look before your next DHA conversation. Knowing the seat is settled is worth more than most people will notice this week.

Mary